Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) penned an agreement to renew and increase Sharia-compliant credit facilities with the Saudi National Bank (SNB) on 11 June 2026.
The short-term financing limit has been increased from SAR 200 million previously to SAR 350 million, according to a bourse disclosure.
SPIMACO will use the loan, secured by a promissory note, to finance working capital for nine months.
In the three-month period that ended on 31 March 2026, the company generated net profits valued at SAR 65.10 million, down 8.05% year-on-year (YoY) from SAR 70.80 million. Meanwhile, SNB posted 6.65% YoY higher net profits at SAR 6.42 billion.
